Skip to content

Clinical trials

Phase 4 Hypercholesterolemia trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 4 Country / region: Japan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20081
20091
20102
20111
20162
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kumamoto University2
Yokohama City University Medical Center2
Astellas Pharma Inc1
AstraZeneca1
Kowa Company, Ltd.1
Kyoto University1
National Defense Medical College, Japan1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Regeneron Pharmaceuticals1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia12
Coronary Artery Disease4
Coronary Disease3
Dyslipidemias3
Acute Coronary Syndrome2
Cardiovascular Diseases2
Heart Diseases2
Hyperlipidemias2
Angina Pectoris1
Angina, Stable1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.